荷兰加勒比证券交易所批准CAS Health Holding Group的可交易上市

DCSX has approved the listing of 100,000,000 trade-able shares of CAS Health Holding Group Inc. (DCSX Symbol: CASN) @ USD 0.43 with an initial market capitalization of USD 43Million.  SHKL Group Limited is the mandated Listing Advisor.

 

CAS Health Holding Group Inc. is a limited liability company registered in the Cayman Islands (Company Registration No. AS-351370) and is the listing entity of the operating companies (subsidiaries) registered in China. CAS Health Holding Group Inc. and its ultimate subsidiaries CASUWIN Heibei Biotechnology Co. Ltd. and CASUWIN (Beijing) Biotechnology Co. Ltd. are high-tech enterprises specializing in R&D, production and sales of Food for Special Medical Purpose focused on the characteristics of clinical patients and Chinese people’s healthy nutrition needs.

 

Headquarter of the Group is based in Shijiazhuang, He Bei Province, China, and was established in 2011. They intend to achieve their business objective of increasing their market share and strengthening their market position in the supply of “Food for Special Medical Purpose” in China, by expanding their product sales coverage to 3-4 additional provinces and increase their product variety. They expect to acquire 0.5% -1% of the total market share in China in 5 years and become one of the local major market leaders in Heibei Province.

 

In connection with and for the purpose of the Listing, existing shareholders restructured their interests in the operating companies so that existing shareholders hold their interests in the operating companies indirectly through their shareholdings in the Group in the proportion of their interests in the equity capital of the operating company prior to the restructuring. The Group applied for a tradeable listing of the presently issued and outstanding shares. In other words, the Group does not raise or will not raise or receive new funds with this listing. However, the Group and/or its shareholders may wish to trade their existing shares through listing on the DCSX which will create liquidity for existing shares of the Group.

 

Further details about the business will be found on our Markets page on this website under Equities Symbol CASN, section Company Information.

 

翻译：

 

DCSX已批准以100股0.43美元的价格上市100,000,000股CAS Health Holding Group Inc. （DCSX代号：CASN）的可  交易股票，初始市值为4,300万美元。SHKL Group Limited  是授权的上市顾问。

 

CAS Health Holding Group Inc.是在开曼群岛注册的有限责任公司（公司注册号AS-351370），并且是在中国注册的运营公司（子公司）的上市实体。CAS Health Holding Group Inc.及其最终子公司CASUWIN河北生物技术有限公司和CASUWIN（北京）生物技术有限公司是专注于特殊用途食品的研发，生产和销售的高科技企业。临床患者和中国人的健康营养需求。

 

集团总部设在中国河北省石家庄市，成立于2011年。他们的目标是实现其市场份额的增长并增强其在“特殊医疗食品”供应中的市场地位。中国通过将产品销售覆盖范围扩展到其他3-4个省，并增加了产品种类。他们希望在5年内获得中国市场总份额的0.5％-1％，并成为河北省当地主要的市场领导者之一。

 

就上市而言，就现有股东而言，现有股东重组了其在运营公司中的权益，以使现有股东通过其在集团中的持股比例间接地持有其在运营公司中的权益，而其在本公司股权中所占的比例重组前要经营公司。本集团申请将目前已发行和流通股进行可交易上市。换句话说，本集团不会通过此次上市筹集或将不会筹集或接收新资金。但是，本集团和/或其股东不妨通过在DCSX上上市来交易其现有股票，这将为本集团现有股票创造流动性。

 

有关该业务的更多详细信息，请参见本网站上“  市场”页面上的“股票代码CASN”下的“公司信息”部分。

 

来源：荷兰加勒比证券交易所官网

编辑：金准资本